Review article · 2026 · Open access
Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies
Clinical Pharmacology & Therapeutics, 119(5), 1179–1194 · Published 2 February 2026 · DOI 10.1002/cpt.70224
In brief
“Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies” is a 2026 review article by Rachel K. Scott and 7 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 7 citations as of 17 November 2026, which puts it in the top 2% of works published in 2026 by citations. It is open access under a CC BY licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 7
- Most cited in
- 2026 (7)
- Field-weighted impact
- 7.14
- References
- 88
- Authors
- 8
Abstract
Maternal health remains a critical global concern, particularly in underserved populations and in low- and middle-income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data gaps, hindering informed treatment decisions. As long-acting therapeutics transition into mainstream treatment and prevention strategies, it is critical to ensure these disparities are neither perpetuated nor widened. This review synthesizes insights from the maternal health session of the July 2025 workshop of the Community of Practice for Long-Acting Therapeutics in Maternal and Pediatric Health. It was convened and hosted by the University of Liverpool Centre of Excellence for Long-Acting Therapeutics with funding from Unitaid. Key themes explored during the session include (1) regulatory initiatives, research networks, and data infrastructures that are driving systemic change in maternal health research over the past two decades; (2) important efficacy and safety considerations during pregnancy and lactation using insights from long-acting antiretrovirals currently in clinical use; and (3) selected long-acting drug delivery systems with potential applications in maternal health. Starting with maternal health priorities, here we included further insights regarding long-acting injectable antipsychotics, long-acting reversible contraceptives, and the role of in silico modeling in bridging existing gaps. Several immediately actionable recommendations are presented on advancing long-acting therapeutics for maternal health priorities during pregnancy and lactation.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Scott, R. K., Nachman, S., Weld, E. D., Daley, R., Atoyebi, S., Bies, R. R., Waitt, C. J., & Olagunju, A. (2026). Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies. Clinical Pharmacology & Therapeutics, 119(5), 1179–1194. https://doi.org/10.1002/cpt.70224
MLA 9
Scott, Rachel K., et al. “Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies.” Clinical Pharmacology & Therapeutics, vol. 119, no. 5, 2026, pp. 1179–1194. https://doi.org/10.1002/cpt.70224.
Chicago
Scott, Rachel K., Sharon Nachman, Ethel Derby Weld, Rachel Daley, Shakir Atoyebi, Robert R. Bies, Catriona John Waitt, and Adeniyi Olagunju. 2026. “Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies.” Clinical Pharmacology & Therapeutics 119 (5): 1179–1194. https://doi.org/10.1002/cpt.70224.
Harvard
Scott, R. K. et al. (2026) ‘Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies’, Clinical Pharmacology & Therapeutics, 119(5), pp. 1179–1194. doi:10.1002/cpt.70224.
IEEE
R. K. Scott et al., “Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies,” Clinical Pharmacology & Therapeutics, vol. 119, no. 5, pp. 1179–1194, 2026, doi: 10.1002/cpt.70224.
BibTeX
@article{scott2026advancing,
title = {{Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies}},
author = {Scott, Rachel K. and Nachman, Sharon and Weld, Ethel Derby and Daley, Rachel and Atoyebi, Shakir and Bies, Robert R. and Waitt, Catriona John and Olagunju, Adeniyi},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
volume = {119},
number = {5},
pages = {1179--1194},
doi = {10.1002/cpt.70224},
url = {https://doi.org/10.1002/cpt.70224}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- maternal health
- pregnancy
- lactation
- long-acting injectable antipsychotics
- long-acting reversible contraception
- long-acting antiretrovirals
- drug safety in pregnancy
- drug delivery systems
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Scott, R. K., Nachman, S., Weld, E. D., Daley, R., Atoyebi, S., Bies, R. R., Waitt, C. J., & Olagunju, A. (2026). Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies. Clinical Pharmacology & Therapeutics, 119(5), 1179–1194. https://doi.org/10.1002/cpt.70224
How many times has this paper been cited?
7 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the full text from this page.
Who wrote this paper?
Rachel K. Scott, Sharon Nachman, Ethel Derby Weld, Rachel Daley, Shakir Atoyebi, Robert R. Bies, Catriona John Waitt, Adeniyi Olagunju.
What is the DOI of this paper?
10.1002/cpt.70224, permanently at https://doi.org/10.1002/cpt.70224. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.